ABOUT THE DRUG
In April 2015, an FDA panel said that Onglyza should carry a warning about the increased risk of heart failure.Onglyza (saxagliptin) is an oral diabetes medicine that helps control blood sugar levels by regulating insulin levels after eating. Onglyza is for people with Type 2 diabetes and not for treating Type 1 diabetes.
PURPOSE OF THE DRUG
Along with diet and exercise, Onglyza is designed to help control high blood sugar in people with Type 2 diabetes who do not suffer from diabetic ketoacidosis – a condition where increased ketones are present in the blood or urine.
There are some reports that highlight a possible increased risk of pancreatitis (inflammation of the pancreas) and pancreatic and thyroid cancer.
In April 2015, an FDA panel said that Onglyza should carry a warning about the increased risk of heart failure. Data from the SAVOR study involving 16,000 patients found that people who took Onglyza had a 27 percent greater risk of heart failure hospitalizations than those in the control group.
The agency also warned Onglyza could cause severe joint pain in September 2015.
In addition to the more severe side effects of pancreatitis, pancreatic cancer and heart failure, Onglyza also carries the risk of various other side effects, including diarrhea, headache, nausea and vomiting, stuffy or runny nose, sore throat, upper respiratory tract infection, urinary tract infection, low blood sugar, as well as swelling or fluid retention.
HOW BRAMZON & ASSOCIATES SPECIALTY LITIGATION LLC CAN HELP
“We are facing a ticking time bomb and patients who have taken Onglyza or loved ones who took the drug and encountered some of the potentially life-risking reactions to the drug have to respond immediately,” Despite countless pending lawsuits and wrongful death claims alleging Onglyza was responsible, the drug continues to see strong sales and the manufacturer has failed to provide current and prospective patients with thorough information regarding the potential risks associated with taking the drug. Hundreds who took Onglyza as well as their loved ones have filed lawsuits against the drugs’ makers after they developed pancreatitis or pancreatic cancer, claiming they were not properly warned of the risks.
“We are facing a ticking time bomb and patients who have taken Onglyza or loved ones who took the drug and encountered some of the potentially life-risking reactions to the drug have to respond immediately,” says Bramzon. “The greatest concern is that we still don’t know the full gamut of risk associated with Onglyza, but we do know that the incidence of developing a life-threatening condition is high, so you need to take immediate steps to protect yourself and your loved ones.”
If you or someone you know has taken Onglyza and developed any adverse side effects, you must seek legal representation immediately.